Beyond Biochemical Responses, Use of Histologic Staging to Predict Outcomes of Patients With Primary Biliary Cholangitis

Affiliations

¹ Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
² Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Editorial

Aliya F Gulamhusein et al. Clin Gastroenterol Hepatol. 2020 May.

. 2020 May;18(5):1033-1035.

doi: 10.1016/j.cgh.2019.12.008. Epub 2019 Dec 13.

¹ Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
² Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

No abstract available

Comment on

Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis.
Bowlus CL, Pockros PJ, Kremer AE, Parés A, Forman LM, Drenth JPH, Ryder SD, Terracciano L, Jin Y, Liberman A, Pencek R, Iloeje U, MacConell L, Bedossa P. Bowlus CL, et al. Clin Gastroenterol Hepatol. 2020 May;18(5):1170-1178.e6. doi: 10.1016/j.cgh.2019.09.050. Epub 2019 Oct 10. Clin Gastroenterol Hepatol. 2020. PMID: 31606455 Clinical Trial.